Hepatitis Monthly
Official Journal of Research Center for Gastroenterology and Liver Diseases
Scopus by Title (Ref)
1. Validation of albumin platelet product as a non-invasive fibrosis staging tool in patients with chronic HCV-related liver disease
- Elsabaawy M. , et al.
2. Changing profile and burden of hepatocellular carcinoma in Arab Countries in 1990–2021
- Pan Z. , et al.
3. MAFLD vs. MASLD: a year in review
- Jiang M. , et al.
4. EASL position paper on clinical follow-up after HCV cure
- Reiberger T. , et al.
5. Factors Associated with Large Renal Function Decline in Patients with Chronic Hepatitis C Successfully Treated with Direct-Acting Antiviral Therapy
- Chen C.H. , et al.
7. Hepatitis C treatment outcomes among patients treated in co-located primary care and addiction treatment settings
- Ngo B.V. , et al.
8. Bayesian network modelling study to identify factors influencing the risk of cardiovascular disease in Canadian adults with hepatitis C virus infection
- Badawi A. , et al.
9. Assessment of carotid intima-media thickness and carotid plaque formation among patients with ischemic stroke and hepatitis c virus infection
- Osama A. , et al.
10. The impact of hepatitis c viremia status on lung functions in chronic hepatitis c patients
- Bal T. , et al.
11. Cardiovascular disease risk in patients with hepatitis C infection: Results from two general population health surveys in Canada and the United States (2007-2017)
- Badawi A. , et al.
12. Extrahepatic manifestations in chronic hepatitis C infected patients
- Hagymási K. , et al.
13. The risk of venous thromboembolism in patients with hepatitis c: A systematic review and meta-analysis
- Ambrosino P. , et al.
14. The risk of coronary artery disease and cerebrovascular disease in patients with hepatitis C: A systematic review and meta-analysis
- Ambrosino P. , et al.
15. Does human leukocyte antigen influence the risk of development and type of vasculitis in Egyptian patients with chronic hepatitis C virus infection?
- Shahin A.A. , et al.
16. The prevalence and co-occurrence of hematological complications at the time of diagnosis of chronic hepatitis C in Poland: A cross-sectional study
- Pierucka M. , et al.
17. Antiviral treatment prioritization in HCV-infected patients with extrahepatic manifestations - An Egyptian perspective
- El-Fishawy H. , et al.
18. Predictors of high healthcare resource utilization and liver disease progression among patients with chronic hepatitis C
- Lamori J. , et al.
19. Selective inhibition of hepatitis c virus replication by alpha-zam, a nigella sativa seed formulation
- Oyero O.G. , et al.
20. Genome-Wide Association Studies and Hepatitis C: Harvesting the Benefits of the Genomic Revolution
- Eslam M. , et al.
21. Direct and indirect cost burden of chronic hepatitis C
- Tandon N. , et al.
23. Dermatologic extrahepatic manifestations of hepatitis C
- Dedania B. , et al.
24. Primary renal lymphoma: An unusual presentation of non-Hodgkin′s lymphoma
- Naveen Kumar B.J. , et al.